Diabetes-Alzheimer's connection in older age: SGLT2 inhibitors as promising modulators of disease pathways-Reference-Cited by-同舟云学术

Diabetes-Alzheimer's connection in older age: SGLT2 inhibitors as promising modulators of disease pathways

Published:2023-09 Issue: Volume:90 Page:102018
ISSN:1568-1637
Container-title:Ageing Research Reviews
language:en
Short-container-title:Ageing Research Reviews

Author:

Mancinetti Francesca,Xenos Dionysios,De Fano Michelantonio,Mazzieri Alessio,Porcellati Francesca,Boccardi Virginia^ORCID,Mecocci Patrizia

Publisher

Elsevier BV

Subject

Neurology,Molecular Biology,Aging,Biochemistry,Biotechnology

Reference104 articles.

1. Rosiglitazone and cognitive stability in older individuals with type 2 diabetes and mild cognitive impairment;Abbatecola;Diabetes Care,2010

2. Empagliflozin alleviates neuronal apoptosis induced by cerebral ischemia/reperfusion injury through HIF-1α/VEGF signaling pathway;Abdel-latif;Arch. Pharm. Res,2020

3. Alzheimer’s Facts and Figures Report | Alzheimer’s Association [WWW Document], 2022. URL 〈https://www.alz.org/alzheimers-dementia/facts-figures〉 (accessed 7.14.23).

4. Empagliflozin in heart failure with a preserved ejection fraction;Anker;N. Engl. J. Med.,2021

5. Canagliflozin prevents scopolamine-induced memory impairment in rats: comparison with galantamine hydrobromide action;Arafa;Chem. Biol. Inter.,2017

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. SGLT2 Inhibitors Reduce Uric Acid-Related Adverse Events in Patients with Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis of Randomized Controlled Trials;Journal of Korean Society of Health-System Pharmacists;2023-11-30

2. Glucose Transport and Utilization in the Hippocampus: From Neurophysiology to Diabetes-Related Development of Dementia;International Journal of Molecular Sciences;2023-11-18

3. Multimodal Precision Prevention - A New Direction in Alzheimer’s Disease;The Journal of Prevention of Alzheimer's Disease;2023